Evidence map›Paper›PMID 30254034›Full record

ArticleAnnals of the rheumatic diseases2019

Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification.

Zhenhuan Zhao, Jiling Ren, Chao Dai, Carol C Kannapell, Hongyang Wang, Felicia Gaskin, Shu Man Fu

Open access · greenAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. [Role of HLA genetic variants in autoimmune diseases].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Peptide-based immunotherapy in lupus: Where are we now?Rheumatology and immunology research · 2023
    Review
  10. Article
  11. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  12. Review
  13. Review
  14. Review
  15. Gut microbiome and autoimmune disorders.Clinical and experimental immunology · 2022
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhenhuan Zhao *Division of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Jiling Ren *Division of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Chao DaiDivision of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Carol C KannapellDivision of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Hongyang WangDivision of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Felicia GaskinDepartment of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia, USA.
Shu Man FuDivision of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA sf2e@virginia.edu.
University of Virginia · US

Funding

Cellular and Genetic Basis of Systemic LupusR01AR047988 · NIAMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI FU, SHU MAN · 2001 to 2020
$8.4M
Infections, Microbiome and HLA-DR in the Induction of Lupus Related Auto-antibodiesR01AI139673 · NIAID · UNIVERSITY OF VIRGINIA · PI SUNG, SUN-SANG JOSEPH · 2018 to 2022
$2.8M
Targeting Treg for Therapy of Lupus GlomerulonephritisR01DK105833 · NIDDK · UNIVERSITY OF VIRGINIA · PI FU, SHU MAN, SHARMA, RAHUL · 2016 to 2019
$1.4M
NIAID NIH HHS R01 AI139673NIAMS NIH HHS R01 AR047988NIDDK NIH HHS R01 DK105833
6 · The paper itself

Abstract

objectivesThe generation of systemic lupus erythematosus (SLE)-related autoantibodies have been shown to be T cell dependent and antigen driven with HLA-DR restriction. In this study, the initiating antigen(s) and the mechanism of autoantibody diversification were investigated.

methodsT cell epitopes (T-epitopes) of SmD1 (SmD) were mapped by T-T hybridomas generated from DR3

resultsMultiple HLA-DR3 restricted T-epitopes within SmD were identified. Many T-T hybridomas reacted with more than one epitope. Some of them were cross-reactive with other snRNP peptides and with proteins in the Ro60/La/Ro52 complex. The reactive hybridomas used unique TCRs. Multiple T-epitope mimics were identified in commensal and environmental bacteria. Certain bacterial mimics shared both T and B cell epitopes with the related SmD peptide. Bacterial mimics induced autoantibodies to lupus-related antigens and to different tissues. HLA-DR3

conclusionsThe unique antigenic structures of the lupus-related autoantigens provide the basis for being targeted and for T and B cell epitope spreading and autoantibody diversification with unique patterns. SLE-related autoantibodies are likely generated from responses to commensal and/or environmental microbes due to incomplete negative selection for autoreactive T cells. The production of SLE-related antibodies is inevitable in normal individuals. The findings in this investigation have significant implications in autoimmunity in general.

Indexed as

AnimalsAutoantibodiesAutoantigensAutoimmunityCross ReactionsDisease Models, AnimalEpitopes, T-LymphocyteHLA-DR AntigensLupus Erythematosus, SystemicMicesnRNP Core ProteinsAutoantibodiesAutoantigensEpitopes, T-LymphocyteHLA-DR AntigenssnRNP Core ProteinsautoantibodyHLA-DRmolecular mimicrySLET cell epitopes

Identifiers

PMID30254034
PMCPMC6377330
OpenAlexW2893594818

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.